<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02774122</url>
  </required_header>
  <id_info>
    <org_study_id>961619</org_study_id>
    <nct_id>NCT02774122</nct_id>
  </id_info>
  <brief_title>Cochleural Alternating Acoustic Beam Therapy (CAABT) Versus Masking Intervention for Tinnitus</brief_title>
  <official_title>Cochleural Alternating Acoustic Beam Therapy Versus Masking Intervention for Tinnitus: A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Friendship Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to compare the effectiveness of CAABT and masking therapy in the management of
      subjective tinnitus in adults.Half of participants will receive CAABT, while the other half
      will receive masking therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Masking intervention was a standard monophone tinnitus masking therapy. It was usually a
      narrow-band noise matched with tinnitus frequency (Tf).

      CAABT was an innovative tinnitus intervention which based on neural science and cochlear
      plastic research and aimed to reprogram the central auditory system to neutralize the
      discordant responses of the dysfunctioning cochlea via acoustic beaming stimuli.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in Tinnitus Subjective Measures at 12 weeks: pure tone audiometry</measure>
    <time_frame>baseline and 12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in Tinnitus Subjective Measures at 12 weeks: tinnitus loudness</measure>
    <time_frame>baseline and 12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in Tinnitus Subjective Measures at 12 weeks: minimize masking level</measure>
    <time_frame>baseline and 12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in Tinnitus Subjective Measures at 12 weeks: the Chinese version of Tinnitus Handicap Inventory scale</measure>
    <time_frame>baseline and 12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in Tinnitus Subjective Measures at 12 weeks: the Visual Analog Scale</measure>
    <time_frame>baseline and 12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Tinnitus Objective Measure at 12 weeks: functional magnetic resonance imaging (fMRI)</measure>
    <time_frame>baseline and 12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Tinnitus, Subjective</condition>
  <arm_group>
    <arm_group_label>masking therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Masking intervention was a standard monophone tinnitus masking therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CAABT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CAABT was an innovative tinnitus intervention which based on neural science and cochlear plastic research and aimed to reprogram the central auditory system to neutralize the discordant responses of the dysfunctioning cochlea via acoustic beaming stimuli.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CAABT</intervention_name>
    <description>CAABT was an innovative tinnitus intervention which based on neural science and cochlear plastic research and aimed to reprogram the central auditory system to neutralize the discordant responses of the dysfunctioning cochlea via acoustic beaming stimuli.</description>
    <arm_group_label>CAABT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>masking therapy</intervention_name>
    <description>Masking intervention was a standard monophone tinnitus masking therapy.</description>
    <arm_group_label>masking therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Unilateral tinnitus

          -  Ages between 18-80 years

          -  Tinnitus undergone for more than 6 months

          -  Hearing loss of the tinnitus ear not affect communication

          -  The main tinnitus frequency is less than 8 KHz

          -  Primary tinnitus

        Exclusion Criteria:

          -  Secondary tinnitus

          -  Hyperacusis

          -  Patients were accepting any therapy about tinnitus

          -  Those who have serious mental illness

          -  Patients who can't fit the audiological examination and tinnitus tests

          -  Most of the hearing loss in the middle and severe hearing loss of the tinnitus ear

          -  Any MRI contraindications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gong shu-sheng, MD</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Friendship Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Otorhinolaryngology Head and Neck Surgery department</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100031</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.sciencedirect.com/science/article/pii/S0140673612604693</url>
    <description>Clinical Key links</description>
  </link>
  <results_reference>
    <citation>Cima RF, Maes IH, Joore MA, Scheyen DJ, El Refaie A, Baguley DM, Anteunis LJ, van Breukelen GJ, Vlaeyen JW. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial. Lancet. 2012 May 26;379(9830):1951-9. doi: 10.1016/S0140-6736(12)60469-3.</citation>
    <PMID>22633033</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2016</study_first_submitted>
  <study_first_submitted_qc>May 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 17, 2016</study_first_posted>
  <last_update_submitted>January 20, 2018</last_update_submitted>
  <last_update_submitted_qc>January 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Friendship Hospital</investigator_affiliation>
    <investigator_full_name>Shu-sheng Gong</investigator_full_name>
    <investigator_title>director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>individual participant data(IPD) for all subjective and objective outcome measures will be made available within 6 months of study completion</ipd_description>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>22633033</doc_id>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>http://www.sciencedirect.com/science/article/pii/S0140673612604693</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

